Aurora Cannabis Expands Testing Capabilities With Chemi Pharmaceutical Acquisition

Canadian cannabis producer Aurora Cannabis Inc (NYSE: ACB) said Thursday that it entered into a binding share purchase agreement to acquire Ontario-based laboratory operator Chemi Pharmaceutical.

What Happened

The acquisition will be conducted in cash and stock. Aurora did not disclose the amount, but said it would pay Chemi Pharmaceutical shareholders 83,299 shares on closing, which equates to roughly …

Full story available on Benzinga.com

More Aurora Cannabis Expands Testing Capabilities With Chemi Pharmaceutical Acquisition